Document Detail


Assessing baroreflex sensitivity in post-myocardial infarction patients: comparison of spectral and phenylephrine techniques.
MedLine Citation:
PMID:  9462578     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: This study sought to compare, in post-myocardial infarction patients, baroreflex sensitivity (BRS) measured by the phenylephrine method (Phe-BRS) with that estimated by the Robbe (Robbe-BRS) and Pagani (alpha-low frequency [LF] and alpha-high frequency [HF]) spectral techniques. BACKGROUND: BRS assessed by Phe-BRS has been shown to be of prognostic value in patients with a previous myocardial infarction, but the need for drug injection limits the use of this technique. Several noninvasive methods based on spectral analysis of systolic arterial pressure and heart period have been proposed, but their agreement with Phe-BRS has never been investigated in post-myocardial infarction patients. METHODS: The linear association and the agreement between each spectral measurement and Phe-BRS were assessed by correlation analysis and by computing the relative bias and the limits of agreement in 51 post-myocardial infarction patients. RESULTS: The correlation with Phe-BRS was r = 0.63 for Robbe-BRS, r = 0.62 for alpha-LF and r = 0.59 for alpha-HF. The relative bias was significant for alpha-LF (2.6 ms/mm Hg, p < 0.001) and alpha-HF (2.5 ms/mm Hg, p = 0.01) and not significant (-0.6 ms/mm Hg, p = 0.3) for Robbe-BRS. The normalized limits of agreement ranged from -98% to 95% for Robbe-BRS, from -67% to 126% for alpha-LF and from -108% to 143% for alpha-HF. When patients were classified according to left ventricular ejection fraction (LVEF, cutoff value 40%), the relative bias was higher in patients with a depressed LVEF, although statistical significance was high only for Robbe-BRS and was borderline for alpha-LF. The limits of agreement were similar in both groups of patients (p > 0.3). CONCLUSIONS: Despite a substantial linear association, the agreement between spectral measurements and Phe-BRS in post-myocardial infarction patients is weak because the difference can be as large as the BRS value being estimated. Phe-BRS is the measurement most associated with hemodynamic impairment. Because several factors within each method contribute to the overall difference, neither method can be defined as being better than the other in estimating baroreflex gain, nor can one be used as an alternative to the other. Ad hoc studies are needed to assess which method provides the most useful physiologic or pathophysiologic information or the most accurate prediction of prognosis.
Authors:
R Maestri; G D Pinna; A Mortara; M T La Rovere; L Tavazzi
Related Documents :
10573498 - Total cavopulmonary and atriopulmonary connections are associated with reduced heart ra...
24016488 - Overview of the 2012 food and drug administration circulatory system devices panel meet...
9412538 - Adrenergic nervous system in heart failure.
8106828 - Cardiac dysrhythmias associated with central nervous system dysfunction.
11182708 - Tc-99m sestamibi defect magnitude predicts the amount of viable myocardium after corona...
16500498 - Coronary flow velocity pattern assessed noninvasively by transthoracic color doppler ec...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  31     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  1998 Feb 
Date Detail:
Created Date:  1998-02-26     Completed Date:  1998-02-26     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  344-51     Citation Subset:  AIM; IM    
Affiliation:
Department of Biomedical Engineering, Institute of Care and Scientific Research, Rehabilitation Institute of Montescano, Pavia, Italy. bing@fsm.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Baroreflex / physiology*
Bias (Epidemiology)
Blood Pressure / drug effects,  physiology*
Electrocardiography / drug effects
Female
Forecasting
Humans
Linear Models
Male
Middle Aged
Myocardial Contraction / drug effects,  physiology*
Myocardial Infarction / physiopathology*
Phenylephrine / diagnostic use*
Prognosis
Sensitivity and Specificity
Signal Processing, Computer-Assisted
Stroke Volume / physiology
Systole
Vasoconstrictor Agents / diagnostic use*
Ventricular Function, Left / physiology
Chemical
Reg. No./Substance:
0/Vasoconstrictor Agents; 59-42-7/Phenylephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial ...
Next Document:  Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable c...